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Effect of Particle Size on Bioavailability of Carbamazepine 
Administered as a Nanoemulsion
Jinwon Byun, Derrick Chapman, Rebecca Kyper, Gina Mattes, and Zachary Wallace  |  Dr. Elisha Injeti  |  Cedarville University 
Introduction 
 Carbamazepine (CBZ) is an anticonvulsant drug
primarily used to treat epilepsy, bipolar disorder,
trigeminal and glossopharyngeal neuralgia.
 CBZ is a lipophilic and poorly soluble drug with
limited ability to diffuse across biological
membranes.
 To increase its bioavailability, CBZ is formulated
into specialized nanoemulsions called Self
Nano-Emulsifying Drug Delivery Systems
(SNEDDS).
 SNEDDS are isotropic mixtures of oil,
surfactants and cosurfactants that form fine oil-
in-water nanoemulsions upon mild agitation,
followed by injection into aqueous media of
gastrointestinal tract.
 SNEDDS have shown to reduce the particle size
of CBZ molecules and improve its solubility and
ability to cross the biological membranes1.
 However, the in-vivo bioavailability of CBZ in
SNEDDS hasn’t been investigated.
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 The study will be conducted as a randomized 
controlled crossover experiment utilizing a rat 
model.
 Sprague-Dawley rats (n=12) will be divided 
randomly into two groups of same size.
 One group will be administered CBZ in standard 
formulation and SNEDDS for other group.
 After administration, blood samples will be 
collected at 5, 10, 15, 20, 30, 45, 60, 90, and 120 
minutes2.
 Tail vein incision method will be used to collect 
blood samples.
 Samples will be stored at -20°C until ready for 
analysis2. 
 CBZ in blood samples will be analyzed by reversed 
phase High Performance Liquid Chromatography  
(HPLC). 
 The objective of this study is to study the effect of 
particle size on in-vivo bioavailability of CBZ 
administered as SNEDDS compared to a standard 
formulation 
 An unpaired t-test will be used to compare the 
significance between the two sets of data.
Results and Conclusions 
 Bioavailability is expected to increase due to the 
deceased particle size of SNEDDS formulation. 
 Limitations include a small sample size which will 
lower statistical power of the results.
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